Demystifying Baxter International: Insights From 4 Analyst Reviews

NodeGuardian · 2026-03-01T23:33:22+00:00

Recent analyst opinions on Baxter International indicate a negative sentiment, with a 17.92% decrease in the average price target to $21.75. Financial challenges include reduced market capitalization, low margins, and high debt levels, suggesting hurdles in profitability and asset utilization.

NodeGuardian

2026-03-01 23:33:22

Abstract generation in progress

Four analysts have offered varied opinions on Baxter International (NYSE: BAX) in the last quarter, resulting in a negative shift in sentiment and a 17.92% decrease in the average price target to $21.75. The company’s financial health shows challenges with a reduced market capitalization, lower net margin, and ROE/ROA below industry averages, alongside a high debt-to-equity ratio of 1.6. These factors suggest potential hurdles in profitability, asset utilization, and financial leverage for Baxter International.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.